Christopher Patusky, Director: United Therapeutics UTHR Sell · Filed 25/01/13

Trade details

Type: Insider sale
Amount: $698,717.9
Shares · price: 1,930 sh · $362.03 a share
Held after: 2,101 sh
Stock: United Therapeutics UTHR
Person: Christopher PatuskyDirector
Trade date: 25/01/10
Filed: 25/01/13
Days to filing: 3 days

Sold 47.9% of holdings

Share of holding sold: 47.9%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/11~25/02/09

Christopher Patusky's recent trades

Christopher PatuskyDirector
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$1.7M
2,910 sh
$1.7M
Filed 04/24
Traded 04/24
Christopher PatuskyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$1.7M
2,910 sh
$1.7M
Filed 04/24
Traded 04/24
Christopher PatuskyDirector
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$578.9K
1,000 sh
$578.9K
Filed 04/17
Traded 04/17
Christopher PatuskyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$578.9K
1,000 sh
$578.9K
Filed 04/17
Traded 04/17
Christopher PatuskyDirector
SellUnited Therapeutics
Sell
United Therapeutics
UTHR
$496K
1,000 sh
$496K
Filed 25/12/16
Traded 25/12/15

Christopher Patusky, Director — sold $698.7K of United Therapeutics UTHR · 47.9% of holdings · 10b5-1 plan | Whalegun